Shock Jocks

Date: July 21, 1997 Comparison Chart What do Frankenstein's monster and Dolly the sheep have in common? Electricity brought them both to life. New life has been given to those performing transfection experiments through the power of electroporation. While chemical methods have long been the most frequently used means for cellular transfections, for many, electroporation is the preferred protocol. Electroporation transfection rates for some cell types are generally touted as being several order

Written byLaura Defrancesco
| 12 min read

Register for free to listen to this article
Listen with Speechify
0:00
12:00
Share

Date: July 21, 1997 Comparison Chart

What do Frankenstein's monster and Dolly the sheep have in common? Electricity brought them both to life. New life has been given to those performing transfection experiments through the power of electroporation. While chemical methods have long been the most frequently used means for cellular transfections, for many, electroporation is the preferred protocol. Electroporation transfection rates for some cell types are generally touted as being several orders of magnitude higher than those for chemical transformation and the experiments take minutes rather than hours. As you'll see in this profile, manufacturers of today's version of electroporators have developed machines that are safer to use than the devices of 25 years ago, user-friendly, and versatile in performance. The initial capital outlay for these devices may appear costly to some, but factoring in the savings of time and materials can make them worth the investment.

Electroporation was ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies